BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/23/2025 6:25:20 AM | Browse: 65 | Download: 273
 |
Received |
|
2025-08-04 11:24 |
 |
Peer-Review Started |
|
2025-08-04 11:24 |
 |
First Decision by Editorial Office Director |
|
2025-08-27 09:25 |
 |
Return for Revision |
|
2025-08-27 16:09 |
 |
Revised |
|
2025-09-09 08:05 |
 |
Publication Fee Transferred |
|
2025-09-11 06:01 |
 |
Second Decision by Editor |
|
2025-11-12 02:45 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-11-13 01:23 |
 |
Articles in Press |
|
2025-11-13 01:23 |
 |
Edit the Manuscript by Language Editor |
|
2025-11-17 00:33 |
 |
Typeset the Manuscript |
|
2025-12-10 01:33 |
 |
Publish the Manuscript Online |
|
2025-12-23 06:25 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Yin Yang 1 activates JAK-STAT3-mediated epithelial-mesenchymal transition in Helicobacter pylori-induced gastric cancer progression
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Wan Chen, Jie-Ji Ouyang, Zhen-Hui Wang, Di-Meng Ma, Zhi Zhang, Qiong Teng, Gang Yu and Xiang-Yong Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 82372646 |
| Research Fund of Anhui Institute of Translational Medicine |
No. 2023zhyx-C70 and No. 2023zhyx-C80 |
|
| Corresponding Author |
Xiang-Yong Li, Chief Physician, PhD, Professor, Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Shushan District, Hefei 230022, Anhui Province, China. liyongxiang@ahmu.edu.cn |
| Key Words |
Helicobacter pylori; Gastric cancer; Yin Yang 1; Janus kinase 2/signal transducer and activator of transcription 3; Epithelial-mesenchymal transition |
| Core Tip |
This study revealed that Yin Yang 1 (YY1) was upregulated in Helicobacter pylori-induced gastritis and gastric cancer, where it promoted tumor proliferation, invasion, epithelial-mesenchymal transition, and growth by directly activating Janus kinase 2 transcription and enhancing Janus kinase 2/signal transducer and activator of transcription 3 phosphorylation. YY1 knockdown or pharmacological inhibition reversed these malignant phenotypes. These findings elucidate a key mechanistic pathway in gastric carcinogenesis and identify YY1 as a potential therapeutic target for Helicobacter pylori-associated malignancy. |
| Publish Date |
2025-12-23 06:25 |
| Citation |
Chen JW, Ouyang JJ, Wang ZH, Ma DM, Zhang Z, Teng Q, Yu G, Li XY. Yin Yang 1 activates JAK-STAT3-mediated epithelial-mesenchymal transition in Helicobacter pylori-induced gastric cancer progression. World J Clin Oncol 2025; 16(12): 112626 |
| URL |
https://www.wjgnet.com/2218-4333/full/v16/i12/112626.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v16.i12.112626 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.